H. Qiu, S. Cao, Ruihua Xu
2021.7.20Cancer Communications
tlooto Summary
The Chinese authorities should adjust the national cancer control program with reference to the practices of cancer control which have been well-established in the developed countries, and taking consideration of the diversity of cancer types by of different regions in China at the same time.
Abstract
Cancer is one of the leading causes of death and a main economic burden in China. Investigating the differences in cancer patterns and control strategies between China and developed countries could provide reference for policy planning and contribute to improving cancer control measures. In this study, we reviewed the rates and trends of cancer incidence and mortality and disability‐adjusted life year (DALY) burden in China, and compared them with those in the United States (US) and the United Kingdom (UK).
Citation format
QIU, H.; CAO, S.; XU, Ruihua. Cancer incidence, mortality, and burden in China: A time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Communications, 2021, 41: 1037–1048.